These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16357094)

  • 1. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure.
    Damgaard M; Norsk P; Gustafsson F; Kanters JK; Christensen NJ; Bie P; Friberg L; Gadsbøll N
    Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1294-301. PubMed ID: 16357094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure.
    Volpe M; Tritto C; DeLuca N; Rubattu S; Rao MA; Lamenza F; Mirante A; Enea I; Rendina V; Mele AF
    Circulation; 1993 Oct; 88(4 Pt 1):1620-7. PubMed ID: 8403308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure.
    Gabrielsen A; Bie P; Holstein-Rathlou NH; Christensen NJ; Warberg J; Dige-Petersen H; Frandsen E; Galatius S; Pump B; Sørensen VB; Kastrup J; Norsk P
    Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R459-67. PubMed ID: 11448848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism.
    Magri P; Rao MA; Cangianiello S; Bellizzi V; Russo R; Mele AF; Andreucci M; Memoli B; De Nicola L; Volpe M
    Circulation; 1998 Dec 22-29; 98(25):2849-54. PubMed ID: 9860786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial.
    Florea VG; Rector TS; Anand IS; Cohn JN
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition.
    Volpe M; Magri P; Rao MA; Cangianiello S; DeNicola L; Mele AF; Memoli B; Enea I; Rubattu S; Gigante B; Trimarco B; Epstein M; Condorelli M
    Hypertension; 1997 Aug; 30(2 Pt 1):168-76. PubMed ID: 9260976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary Sodium Intake is Predicted by Antihypertensive Medication Regimen in Patients With Heart Failure.
    Smith JL; Lennie TA; Chung ML; Mudd-Martin G
    J Cardiovasc Nurs; 2019; 34(4):313-318. PubMed ID: 30855313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
    Kjaer A; Hesse B
    Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla.
    DiBona GF; Jones SY
    Hypertension; 2001 Apr; 37(4):1114-23. PubMed ID: 11304512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of sodium and water retention in heart failure.
    Cadnapaphornchai MA; Gurevich AK; Weinberger HD; Schrier RW
    Cardiology; 2001; 96(3-4):122-31. PubMed ID: 11805379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral responses to exercise in patients with congestive heart failure.
    Ueyama M; Nishimura H; Kubota J; Kawamura K
    Jpn Circ J; 1993 May; 57(5):411-7. PubMed ID: 8099632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure.
    Damgaard M; Goetze JP; Norsk P; Gadsbøll N
    Eur Heart J; 2007 Nov; 28(22):2726-31. PubMed ID: 17942579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure.
    Gabrielsen A; Sørensen VB; Pump B; Galatius S; Videbaek R; Bie P; Warberg J; Christensen NJ; Wroblewski H; Kastrup J; Norsk P
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1931-40. PubMed ID: 11009482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
    Kiowski W; Zuber M; Elsasser S; Erne P; Pfisterer M; Burkart F
    Am Heart J; 1991 Nov; 122(5):1382-8. PubMed ID: 1683143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.